Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.

Rodolfo SaccoDaryl RamaiRaffaella TortoraGiovan Giuseppe di CostanzoMichela Emma BurloneMario Pirisi Piera Federico Bruno Daniele Marianna Silletta Paolo GalloCaterina CocuzzaMaurizio RusselloGiuseppe CabibboGabriele RancatoreSilvia CesarioGianluca MasiLuca Marzi Andrea Mega Alessandro GranitoGiulia PieriEdoardo Giovanni GianniniRosa PaolilloGennaro Gadaleta-CaldarolaVincenzo DadduzioGuido GiordanoLuca GiacomelliSimonetta PapaMatteo Renzulli Marcello Maida Michele GhidiniMauro BorzioAntonio Facciorussonull null

Published in: Cancers (2023)

Patients affected by HCC with nonviral etiology treated with lenvatinib exhibit longer survival than those with viral etiology. This finding may have relevance in the treatment decision-making process.

Keyphrases

end stage renal disease
decision making
newly diagnosed
ejection fraction
chronic kidney disease
sars cov
peritoneal dialysis
prognostic factors
depressive symptoms
patient reported
replacement therapy